搜索
Olema Pharmaceuticals Inc
OLMA添加自选
9.510USD
+0.070+0.74%
收盘 06/18, 16:00（美东）报价延迟15分钟
830.67M总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Paradigm BioCapital Advisors LP
8.64%
Janus Henderson Investors
7.68%
BVF Partners L.P.
6.06%
Fidelity Management & Research Company LLC
5.41%
Invus Public Equities Advisors, LLC
5.11%
其他
67.10%
持股股东
持股股东
占比
Paradigm BioCapital Advisors LP
8.64%
Janus Henderson Investors
7.68%
BVF Partners L.P.
6.06%
Fidelity Management & Research Company LLC
5.41%
Invus Public Equities Advisors, LLC
5.11%
其他
67.10%
股东类型
持股股东
占比
Investment Advisor
32.77%
Hedge Fund
29.94%
Investment Advisor/Hedge Fund
27.36%
Venture Capital
9.94%
Individual Investor
2.40%
Research Firm
2.11%
Sovereign Wealth Fund
1.02%
Bank and Trust
0.22%
Private Equity
0.19%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
386
94.09M
108.13%
+10.65M
2025Q4
331
71.64M
91.07%
-13.07M
2025Q3
315
72.32M
105.37%
-10.03M
2025Q2
320
70.59M
103.16%
-12.18M
2025Q1
327
72.74M
106.44%
-11.08M
2024Q4
313
78.82M
113.63%
+3.60M
2024Q3
301
63.64M
110.87%
-10.05M
2024Q2
299
62.60M
111.72%
-7.29M
2024Q1
288
60.06M
107.83%
-1.82M
2023Q4
271
55.06M
100.31%
-2.15M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Paradigm BioCapital Advisors LP
7.54M
8.66%
+750.00K
+11.04%
Dec 31, 2025
Janus Henderson Investors
6.71M
7.7%
+3.12M
+87.13%
Dec 31, 2025
BVF Partners L.P.
5.30M
6.08%
--
--
Dec 31, 2025
Fidelity Management & Research Company LLC
4.73M
5.42%
+4.70M
+15962.03%
Dec 31, 2025
Invus Public Equities Advisors, LLC
4.46M
5.12%
+1.16M
+35.18%
Mar 16, 2026
BlackRock Institutional Trust Company, N.A.
4.22M
4.84%
+273.56K
+6.94%
Dec 31, 2025
Logos Global Management LP
3.21M
3.68%
--
--
Dec 31, 2025
Cormorant Asset Management, LP
2.75M
3.16%
+2.75M
--
Dec 31, 2025
RA Capital Management, LP
2.60M
2.98%
+2.60M
--
Dec 31, 2025
查看更多
持股ETF
更新时间: 12月2日 周二
更新时间: 12月2日 周二
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
1.5%
ALPS Medical Breakthroughs ETF
0.25%
iShares Micro-Cap ETF
0.1%
Invesco Nasdaq Biotechnology ETF
0.06%
ProShares Ultra Nasdaq Biotechnology
0.06%
iShares Health Innovation Active ETF
0.06%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.04%
Invesco RAFI US 1500 Small-Mid ETF
0.03%
Avantis US Small Cap Equity ETF
0.03%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比1.5%
ALPS Medical Breakthroughs ETF
占比0.25%
iShares Micro-Cap ETF
占比0.1%
Invesco Nasdaq Biotechnology ETF
占比0.06%
ProShares Ultra Nasdaq Biotechnology
占比0.06%
iShares Health Innovation Active ETF
占比0.06%
iShares Biotechnology ETF
占比0.04%
iShares Russell 2000 Value ETF
占比0.04%
Invesco RAFI US 1500 Small-Mid ETF
占比0.03%
Avantis US Small Cap Equity ETF
占比0.03%
